Abstract
Eosinophilic fasciitis (EF) is characterized by symmetrical thickening of subcutaneous muscular fascia, causing skin induration with wrinkles and prominent hair follicles: the classic peau d’orange. Eosinophilia is a characteristic—albeit not universal—finding. We present the case of a 43-year-old pregnant woman diagnosed with EF during pregnancy who had extensive cutaneous involvement and severe functional repercussions, including worsening of lung function and intrauterine growth restriction as a possible complication. Treatment with prednisone was initiated during gestation and it was necessary to increase the dose. After delivery, methotrexate treatment was initiated and the corticosteroid dose progressively decreased, with progressive worsening in the torso and abdomen and secondary dyspnea due to thoracic pressure. Treatment with infliximab was then initiated, with favorable progress, though residual ankle and tarsal joint stiffness and significant muscular atrophy in the limbs continued. The triggering factor of EF was not identified. In a systematic search of the medical literature, three cases of EF in pregnant woman without clear triggers were found. Interestingly, all three cases progressed favorably with steroid treatment. Apart from this case, there are only seven published cases of infliximab use in the literature, all with moderate or complete response. Infliximab could be an option for corticosteroid-dependent EF with no response to other options.
Similar content being viewed by others
References
Shulman LE (1975) Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 88:70–86
Rodnan GP, Di Bartolomeo A, Medsger TA (1975) Proceedings: EOSINOPHILIC fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum 18(5):525
Pinal-Fernandez I, Selva O, Callaghan A, Grau JM (2014) Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 13(4–5):379–382
Ihn H (2019) Eosinophilic fasciitis: from pathophysiology to treatment. Allergol Int 68(4):437–439
Amdur HS, Levin RE (1989) Eosinophilic fasciitis during pregnancy. Obstet Gynecol 73(5 Pt 2):843–847
Strosberg JM (1979) Eosinophilic fasciitis following pregnancy. JAMA 241(20):2144
Fonseca MES, Quaresma MV, Luppino-Assad AP, da Silva HC, Andrade DCO, Sampaio-Barros PD (2018) Eosinophilic fasciitis during pregnancy: case report and review of literature. Rheumatol Int 38(3):525–529
Mertens JS, Thurlings RM, Kievit W, Seyger MMB, Radstake TRD, de Jong EMGJ (2017) Long-term outcome of eosinophilic fasciitis: a cross-sectional evaluation of 35 patients. J Am Acad Dermatol 77(3):512-517.e5
Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17(4):221–231
Lebeaux D, Francès C, Barete S, Wechsler B, Dubourg O, Renoux J et al (2012) Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 51(3):557–561
Nassonova VA, Ivanova MM, Akhnazarova VD, Oskilko TG, Bjelle A, Hofer PA et al (1979) Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol 8(4):225–233
Killen JW, Swift GL, White RJ (2000) Eosinophilic fasciitis with pulmonary and pleural involvement. Postgrad Med J 76(891):36–37
Rizzo S (2002) Eosinophilic pleuropericarditis and fasciitis. A new case. Monaldi Arch Chest Dis 57(5–6):311–313
Kirschstein M, Helmchen U, Jensen R, Küster RM, Lehmann H (1999) Kidney involvement in a 17-year-old boy with eosinophilic fasciitis. Clin Nephrol 52(3):183–187
Long H, Zhang G, Wang L, Lu Q (2016) Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol 50(2):189–213
Kim HJ, Lee S-W, Kim GJ, Lee J-H (2014) Usefulness of FDG PET/CT in the diagnosis of eosinophilic fasciitis. Clin Nucl Med 39(9):801–802
Kissin EY, Garg A, Grayson PC, Dubreuil M, Vradii D, York M et al (2013) Ultrasound assessment of subcutaneous compressibility: a potential adjunctive diagnostic tool in eosinophilic fasciitis. J Clin Rheumatol 19(7):382–385
Jinnin M, Yamamoto T, Asano Y, Ishikawa O, Sato S, Takehara K et al (2018) Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis. J Dermatol 45(8):881–890
Lebeaux D, Sène D (2012) Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 26(4):449–458
Nashel J, Steen V (2015) The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis. Clin Rheumatol 34(8):1481–1484
Balk EM, Earley A, Avendano EA, Raman G (2016) Long-term health outcomes in women with silicone gel breast implants: a systematic review. Ann Intern Med 164(3):164
Kivity S, Katz M, Langevitz P, Eshed I, Olchovski D, Barzilai A (2012) Autoimmune Syndrome Induced by Adjuvants (ASIA) in the Middle East: morphea following silicone implantation. Lupus 21(2):136–139
Blagojevic J, AlOdhaibi KA, Aly AM, Bellando-Randone S, Lepri G, Bruni C et al (2020) Pregnancy in systemic sclerosis: results of a systematic review and metaanalysis. J Rheumatol 47(6):881–887
Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA (2016) Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol 152(1):97–99
Mazori DR, Femia AN, Vleugels RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19(12):74
Endo Y, Tamura A, Matsushima Y, Iwasaki T, Hasegawa M, Nagai Y et al (2007) Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 26(9):1445–1451
Mertens JS, Zweers MC, Kievit W, Knaapen HKA, Gerritsen M, Radstake TRDJ et al (2016) High-dose intravenous pulse methotrexate in patients with eosinophilic fasciitis. JAMA Dermatol 152(11):1262–1265
Tkachenko E, Steuer AB, Lo K, LaChance A, Merola JF, Femia AN et al (2020) Mycophenolate mofetil for eosinophilic fasciitis: a retrospective analysis from 3 tertiary care centers. JAMA Dermatol 15:595
Tull R, Hoover WD, De Luca JF, Huang WW, Jorizzo JL (2018) Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission. Drugs Context 7:212529
Loupasakis K, Derk CT (2010) Eosinophilic fasciitis in a pediatric patient. J Clin Rheumatol 16(3):129–131
Vílchez-Oya F, Sánchez-Schmidt JM, Agustí A, Pros A (2020) The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review. Clin Rheumatol 39(5):1693–1698
Urzal J, Cimbron M, Mendonça T, Farinha F (2019) Eosinophilic fasciitis (Shulman’s disease): review and comparative evaluation of seven patients. Reumatologia 57(2):85–90
Espinoza F, Jorgensen C, Pers Y-M (2015) Efficacy of tocilizumab in the treatment of eosinophilic fasciitis: report of one case. Jt Bone Spine 82(6):460–461
Scheinberg M, Hamerschlak N, Kutner JM, Ribeiro AAF, Ferreira E, Goldenberg J et al (2006) Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002–2004). Clin Exp Rheumatol 24(1):65–69
de Masson A, Bouaziz J-D, de Peffault LR, Benhamou Y, Moluçon-Chabrot C, Bay J-O et al (2013) Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature. Medicine (Baltimore) 92(2):69–81
Nahhas AF, Alam M, Lim HW (2018) Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis. Int J Dermatol 57(5):614–615
Kim SR, Charos A, Damsky W, Heald P, Girardi M, King BA (2018) Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib. JAAD Case Rep 4(5):443–445
Cao X-Y, Zhao J-L, Hou Y, Wang F-D, Lu Z-H (2020) Janus kinase inhibitor tofacitinib is a potential therapeutic option for refractory eosinophilic fasciitis. Clin Exp Rheumatol 38(3):567–568
Schiener R, Behrens-Williams SC, Gottlöber P, Pillekamp H, Peter RU, Kerscher M (2000) Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy. Br J Dermatol 142(4):804–807
Bischoff L, Derk CT (2008) Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 47(1):29–35
Tkachenko E, Steuer AB, Lo K, Cobos G, Lo Sicco K, Vleugels RA et al (2019) Intravenous immunoglobulin for refractory eosinophilic fasciitis: a retrospective analysis from 3 tertiary care centers. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2019.12.022
Pimenta S, Bernardes M, Bernardo A, Brito I, Castro L, Simões-Ventura F (2009) Intravenous immune globulins to treat eosinophilic fasciitis: a case report. Jt Bone Spine 76(5):572–574
Bonnotte B, Chauffert B, Caillot D, Martin F, Lorcerie B (1998) Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis. Br J Rheumatol 37(12):1358–1359
Caspi D, Fishel R, Varon M, Yona E, Baratz M, Yaron M (1982) Multisystem presentation of eosinophilic fasciitis. Rheumatol Rehabil 21(4):218–221
Jones AC, Doherty M (1993) Eosinophilic fasciitis with late onset arthritis responsive to sulfasalazine. J Rheumatol 20(4):750–751
Oza VS, Walsh R, North J, Berger TG, Murase JE (2016) Treatment of eosinophilic fasciitis with sirolimus. JAMA Dermatol 152(4):488–490
Mendoza FA, Bai R, Kebede AG, Jimenez SA (2016) Severe eosinophilic fasciitis: comparison of treatment with D-penicillamine plus corticosteroids vs. corticosteroids alone. Scand J Rheumatol 45(2):129–134
Manzini CU, Sebastiani M, Giuggioli D, Manfredi A, Colaci M, Cesinaro AM et al (2012) D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. Clin Rheumatol 31(1):183–187
Suzuki G, Itoh Y, Horiuchi Y (1997) Surgical management of eosinophilic fasciitis of the upper extremity. J Hand Surg Br 22(3):405–407
Neumeister MW, Robertson GA (1998) Therapeutic fasciectomy for eosinophilic fasciitis. Ann Plast Surg 41(2):208–210
Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA (2003) Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 7(5):382–386
Khanna D, Agrawal H, Clements PJ (2010) Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases. Rheumatology (Oxford) 49(6):1184–1188
Poliak N, Orange JS, Pawel BR, Weiss PF (2011) Eosinophilic fasciitis mimicking angioedema and treatment response to infliximab in a pediatric patient. Ann Allergy Asthma Immunol 106(5):444–445
Tzaribachev N, Holzer U, Schedel J, Maier V, Klein R, Kuemmerle-Deschner J (2008) Infliximab effective in steroid-dependent juvenile eosinophilic fasciitis. Rheumatology (Oxford) 47(6):930–932
Yamamoto T, Ito T, Asano Y, Sato S, Motegi S, Ishikawa O et al (2020) Characteristics of Japanese patients with eosinophilic fasciitis: a brief multicenter study. J Dermatol 47:1391–1394
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
All the authors whose names appear on the submission: (1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; (2) drafted the work or revised it critically for important intellectual content; (3) approved the version to be published; and (4) agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Ethical approval (Include appropriate approvals or waivers)
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jiménez-García, N., Aguilar-García, J., Fernández-Canedo, I. et al. Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab. Rheumatol Int 41, 1531–1539 (2021). https://doi.org/10.1007/s00296-021-04787-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-021-04787-6